Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-09-055383
Filing Date
2009-12-07
Accepted
2009-12-07 16:18:30
Documents
1
Period of Report
2009-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd259052.html 4  
1 FORM 4 rrd259052.xml 4 3839
  Complete submission text file 0001181431-09-055383.txt   5638
Mailing Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404
Business Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404 650-358-3300
NeurogesX Inc (Issuer) CIK: 0001385830 (see all company filings)

EIN.: 943307935 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROGESX INC 981 INDUSTRIAL ROAD SUITE F SAN CARLOS CA 94070
Business Address
Tobias Jeffrey K (Reporting) CIK: 0001394522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33438 | Film No.: 091226296